Compare CSV & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CSV | RCEL |
|---|---|---|
| Founded | 1991 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.1M | 405.1M |
| IPO Year | 1996 | 2018 |
| Metric | CSV | RCEL |
|---|---|---|
| Price | $36.21 | $13.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $51.00 | $13.47 |
| AVG Volume (30 Days) | 206.5K | ★ 323.4K |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.25% | N/A |
| EPS Growth | ★ 54.76 | 27.20 |
| EPS | ★ 1.61 | N/A |
| Revenue | ★ $417,440,000.00 | $71,610,000.00 |
| Revenue This Year | $3.77 | $23.37 |
| Revenue Next Year | $5.03 | $29.87 |
| P/E Ratio | $22.44 | ★ N/A |
| Revenue Growth | 3.28 | ★ 11.45 |
| 52 Week Low | $30.11 | $3.22 |
| 52 Week High | $52.10 | $13.73 |
| Indicator | CSV | RCEL |
|---|---|---|
| Relative Strength Index (RSI) | 73.39 | 63.96 |
| Support Level | $33.33 | $3.86 |
| Resistance Level | $40.21 | N/A |
| Average True Range (ATR) | 1.09 | 0.67 |
| MACD | 0.56 | -0.05 |
| Stochastic Oscillator | 92.16 | 71.83 |
Carriage Services Inc is a provider of funeral and cemetery services and merchandise in the United States. It operates in two business segments: The Funeral Home Operations segment offers burial, cremation, and consultation services; removes and prepares remains; sells caskets, urns, and related funeral merchandise. The company enables the use of funeral home facilities for visitation, remembrance, and transportation services. The Cemetery Operations segment provides services, such as mausoleum spaces and niches, private estates, lawn crypt gardens, traditional single burial gravesites, and burial vaults. The majority of revenue is derived from The Funeral Home Operations segment.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.